Procalcitonin accurately predicts mortality but not bacterial infection in COVID-19 patients admitted to intensive care unit
- 16 January 2021
- journal article
- letter
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 190 (4) , 1649-1652
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromesThe Lancet Respiratory Medicine, 2020
- Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysisClinical Microbiology and Infection, 2020
- Bacterial and fungal superinfections in critically ill patients with COVID-19Intensive Care Medicine, 2020
- Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICUAnnals of Intensive Care, 2020
- An inflammatory cytokine signature predicts COVID-19 severity and survivalNature Medicine, 2020
- Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysisClinica Chimica Acta, 2020
- How covid-19 is accelerating the threat of antimicrobial resistanceBMJ, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) StudyCritical Care Medicine, 2017
- Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care settingIntensive Care Medicine, 2015